RPL10 and pancreatic neoplasm: In our previous study, when dimethylamino parthenolide (DMAPT), a water-soluble analogue of parthenolide (PTL), was used as an affinity probe, RPL10 was identified as a direct target protein to affect cell proliferation in pancreatic cancer cell lines of PANC-1 and MIA PaCa-2, suggesting that RPL10 could be a novel target for the treatment of pancreatic cancer [13].